Published in Am J Hematol on October 01, 2005
Update on eosinophilic meningoencephalitis and its clinical relevance. Clin Microbiol Rev (2009) 2.02
Hypereosinophilic syndromes. Orphanet J Rare Dis (2007) 1.53
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol (2012) 1.15
Immunomodulation of allergic disease. Annu Rev Med (2009) 1.02
Löffler endocarditis: a rare cause of acute cardiac failure. J Cardiothorac Surg (2012) 0.95
Macrophage dectin-1 expression is controlled by leukotriene B4 via a GM-CSF/PU.1 axis. J Immunol (2012) 0.94
FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia. BMC Blood Disord (2009) 0.89
ICON: Eosinophil Disorders. World Allergy Organ J (2012) 0.88
Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: Löffler endocarditis. J Gen Intern Med (2008) 0.78
Are various Babesia species a missed cause for hypereosinophilia? A follow-up on the first reported case of imatinib mesylate for idiopathic hypereosinophilia. MedGenMed (2007) 0.75
A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis. Gastroenterology Res (2011) 0.75
Hypereosinophilic syndrome with large intracardiac thrombus. Singapore Med J (2014) 0.75
Diagnostic and therapeutic considerations in idiopathic hypereosinophilia with warm autoimmune hemolytic anemia. J Blood Med (2015) 0.75
A case of hypereosinophilic syndrome presenting with intractable gastric ulcers. World J Gastroenterol (2009) 0.75
Successful treatment of cardiac manifestation of eosinophilic leukemia. Clin Res Cardiol (2010) 0.75
Löffler endocarditis without peripheral eosinophilia. Clin Res Cardiol (2007) 0.75
The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care (2010) 1.66
Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol (2010) 1.19
Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertil Steril (2003) 1.15
The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat (2005) 1.14
The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers. J Clin Pharmacol (2014) 1.11
Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol (2005) 1.11
The pharmacokinetics, pharmacodynamics, and safety of orally dosed INCB018424 phosphate in healthy volunteers. J Clin Pharmacol (2011) 1.07
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers. J Clin Pharmacol (2011) 0.97
Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally. Int J Urol (2007) 0.96
Adverse events from systemic therapies for psoriasis are common in clinical practice. J Dermatolog Treat (2006) 0.89
Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence. BJU Int (2011) 0.80
Risk factors for nonfatal pulmonary embolism in a Japanese population: A hospital-based case-control study. Angiology (2009) 0.80
Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF). Curr Pharm Des (2002) 0.79
Population pharmacokinetic analysis of orally-administered ruxolitinib (INCB018424 Phosphate) in patients with primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET MF). J Clin Pharmacol (2013) 0.79
Effect of topotecan infusion duration on hematologic toxicity in recurrent ovarian carcinoma. Med Oncol (2002) 0.78
Changes in prostate volume in Japanese patients with benign prostatic hyperplasia: association with other urological measures and risk of surgical intervention. Int J Urol (2009) 0.77
Clinical process improvement: reduction of pneumothorax and mortality in high-risk preterm infants. J Perinatol (2002) 0.76
Laboratory tests for rheumatic diseases. Postgrad Med (1995) 0.75
Application of transcriptome analysis to clinical pharmacology studies. Curr Mol Med (2005) 0.75
Changes in the freezing protocol for human zygotes alter embryonic development and pregnancy rates. Fertil Steril (2005) 0.75
Special issue on Catholic social teaching and healthcare reform. Linacre Q (2016) 0.75
Psoriatic arthritis. Postgrad Med (1995) 0.75